Cosmo shares jump on colonoscopy trial results

ZURICH, Nov 10 (Reuters) - Shares in Swiss-listed drugmaker
Cosmo Pharmaceuticals jumped more than 10 percent on
Thursday after it reported its dye tablets helped doctors detect
intestinal growths...